InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Discover the full record of transactions filed by Ho Carole, Directeur Médical. Director active across 1 companies, notably Denali Therapeutics Inc.. In total, 13 filings have been published. Total volume traded: €1.1m. The latest transaction was filed on 11 February 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations13 total
€88,7252,918 shares@ €30.4060.0034% mcap7.7% of flow
Common Stock
SEC:0001714899-22-000039:0·
€46,2221,423 shares@ €32.48210.0018% mcap8.7% of flow
Common Stock
SEC:0001714899-22-000033·
€46,2221,423 shares@ €32.48210.0018% mcap4.0% of flow
Common Stock
SEC:0001714899-22-000033:0·
€112,9062,845 shares@ €39.68580.0044% mcap21.3% of flow
Common Stock
SEC:0001714899-22-000006·
€112,9062,845 shares@ €39.68580.0044% mcap9.8% of flow
Common Stock
SEC:0001714899-22-000006:0·
031,000 shares0
Common Stock
SEC:0001714899-22-000003·
031,000 shares0
Common Stock
SEC:0001714899-22-000003:0·
€55,5161,476 shares@ €37.61230.0022% mcap10.5% of flow
Common Stock
SEC:0001714899-21-000115·
€55,5161,476 shares@ €37.61230.0022% mcap4.8% of flow
Common Stock
SEC:0001714899-21-000115:0·
€255,8256,143 shares@ €41.64490.0099% mcap48.3% of flow
Common Stock
SEC:0001714899-21-000088·
€255,8256,143 shares@ €41.64490.0099% mcap22.3% of flow
Common Stock
SEC:0001714899-21-000088:0·
€59,2061,402 shares@ €42.22980.0023% mcap11.2% of flow
Common Stock
SEC:0001714899-21-000087·
€59,2061,402 shares@ €42.22980.0023% mcap5.2% of flow
Common Stock
SEC:0001714899-21-000087:0·
13 of 13 declarations
About Ho Carole
Carole Ho is the Chief Medical Officer at Denali Therapeutics Inc. She is responsible for the medical strategy and clinical research of the company. Her expertise in biotechnology is essential for the development of innovative treatments and for leading clinical trials.
